BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16682678)

  • 1. Initial pharmacotherapy in a population of veterans with Parkinson disease.
    Swarztrauber K; Koudelka C; Brodsky MA
    Neurology; 2006 May; 66(9):1425-6. PubMed ID: 16682678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescribing pattern of anti-Parkinson drugs in Southern Italy: cross-sectional analysis in the years 2003-2005.
    Trifirò G; Savica R; Morgante L; Vanacore N; Tari M; Moretti S; Galdo M; Spina E; Caputi AP; Arcoraci V
    Parkinsonism Relat Disord; 2008; 14(5):420-5. PubMed ID: 18316232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of recommendations on the initial therapy of Parkinson's disease: a population-based study in France.
    Fayard C; Bonaventure A; Benatru I; Roze E; Dumurgier J; Moisan F; Soumaré A; Houssinot J; Dupupet JL; Mazurie JL; Balaboi I; Houeto JL; Krim E; Ranoux D; Goldberg M; Imbernon E; Moreau T; Giroud M; Tzourio C; Elbaz A
    Parkinsonism Relat Disord; 2011 Aug; 17(7):543-6. PubMed ID: 21612970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentially inappropriate prescribing for the elderly: effects of geriatric care at the patient and health care system level.
    Pugh MJ; Rosen AK; Montez-Rath M; Amuan ME; Fincke BG; Burk M; Bierman A; Cunningham F; Mortensen EM; Berlowitz DR
    Med Care; 2008 Feb; 46(2):167-73. PubMed ID: 18219245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescribing pattern in Parkinson's disease: are cost and efficacy overriding factors?
    Tan EK; Yeo AP; Tan V; Pavanni R; Wong MC
    Int J Clin Pract; 2005 May; 59(5):511-4. PubMed ID: 15857344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physician prescribing rates climb.
    Manag Care; 2002 Sep; 11(9):56. PubMed ID: 12369350
    [No Abstract]   [Full Text] [Related]  

  • 7. Current therapy of Parkinson's disease.
    Ajax T; Rodnitzky R; Dobson J
    Iowa Med; 1997 Jan; 87(1):27-9. PubMed ID: 9029838
    [No Abstract]   [Full Text] [Related]  

  • 8. Postmarketing surveillance of corneal edema, Fuchs dystrophy, and amantadine use in the Veterans Health Administration.
    French DD; Margo CE
    Cornea; 2007 Oct; 26(9):1087-9. PubMed ID: 17893540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug prescribing patterns in Parkinson's disease: a pharmacoepidemiological survey in a cohort of ambulatory patients.
    Leoni O; Martignoni E; Cosentino M; Michielotto D; Calandrella D; Zangaglia R; Riboldazzi G; Oria C; Lecchini S; Nappi G; Frigo G
    Pharmacoepidemiol Drug Saf; 2002 Mar; 11(2):149-57. PubMed ID: 11998540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The quality of pharmacotherapy in older veterans discharged from the emergency department or urgent care clinic.
    Hastings SN; Sloane RJ; Goldberg KC; Oddone EZ; Schmader KE
    J Am Geriatr Soc; 2007 Sep; 55(9):1339-48. PubMed ID: 17767675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of functional age on the use of dopamine agonists in patients with Parkinson disease.
    Silver D
    Neurologist; 2006 Jul; 12(4):214-23. PubMed ID: 16832240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.
    Nemeroff CB; Kalali A; Keller MB; Charney DS; Lenderts SE; Cascade EF; Stephenson H; Schatzberg AF
    Arch Gen Psychiatry; 2007 Apr; 64(4):466-72. PubMed ID: 17404123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How well do psychotropic medications match mental health diagnoses? A national view of potential off-label prescribing in VHA nursing homes.
    French DD; Campbell RR; Spehar AM; Accomando J
    Age Ageing; 2007 Jan; 36(1):107-8; author reply 108-9. PubMed ID: 17158114
    [No Abstract]   [Full Text] [Related]  

  • 14. Incidence, prescription patterns, and determinants of antipsychotic use in patients with Parkinson's disease.
    Wang MT; Lian PW; Yeh CB; Yen CH; Ma KH; Chan AL
    Mov Disord; 2011 Aug; 26(9):1663-9. PubMed ID: 21630354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy for Parkinson's disease.
    Chen JJ; Swope DM
    Pharmacotherapy; 2007 Dec; 27(12 Pt 2):161S-173S. PubMed ID: 18041936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of initial pharmacotherapy for Parkinson's disease in the United States.
    Huse DM; Castelli-Haley J; Orsini LS; Lenhart G; Abdalla JA
    J Geriatr Psychiatry Neurol; 2006 Jun; 19(2):91-7. PubMed ID: 16690994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonphysicians' and physicians' knowledge and care preferences for Parkinson's disease.
    Swarztrauber K; Graf E
    Mov Disord; 2007 Apr; 22(5):704-7. PubMed ID: 17377921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual atypical neuroleptic use: prescribing patterns at a Veterans Affairs outpatient clinic.
    Voris JC
    Manag Care Interface; 2004 Jun; 17(6):28-31. PubMed ID: 15287716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescribing trends in veterans with posttraumatic stress disorder.
    Bernardy NC; Lund BC; Alexander B; Friedman MJ
    J Clin Psychiatry; 2012 Mar; 73(3):297-303. PubMed ID: 22490256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in inpatient antiparkinson drug use in the USA, 2001-2012.
    Crispo JA; Fortin Y; Thibault DP; Emons M; Bjerre LM; Kohen DE; Perez-Lloret S; Mattison D; Willis AW; Krewski D
    Eur J Clin Pharmacol; 2015 Aug; 71(8):1011-9. PubMed ID: 26081062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.